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Abstract 
Purpose: Data regarding the treatment of ureteropelvic junction obstruction (UPJO) in 
horseshoe kidneys are limited. We performed a retrospective analysis of our experience 
with minimally-invasive treatment of UPJO in patients with this anomaly. 
 
Methods: Between March of 1996 and March 2008, 9 patients with horseshoe kidneys 
were treated for UPJO at our institution. Of these patients, 6 were managed with 
retrograde endopyelotomy, 2 with laparoscopic pyeloplasty, and one by robotic 
pyeloplasty. Outcomes of these procedures were retrospectively reviewed. 
 
Results: A total of nine patients were available for analysis. Four of six patients who 
underwent endopyelotomy had available follow-up, with a mean of 56 months. The 
success rate for these patients was 75%. Two of three patients (67%) in the 
laparoscopic/robotic cohort were successfully treated with a mean follow-up of 21 
months. 
 
Conclusions: UPJO in horseshoe kidneys can pose a therapeutic dilemma. The 
minimally-invasive treatment of these patients is feasible with good success rates for both 
endopyelotomy and laparoscopic/robotic pyeloplasty. 
 
Key words: ureteropelvic junction obstruction, horseshoe kidney, endopyelotomy, 
pyeloplasty
Introduction 
Horseshoe kidneys are the most common congenital renal fusion anomaly, 
estimated to occur in 0.1%- 0.25% of births. [1]   Although most horseshoe kidneys are 
asymptomatic, individuals with this anomaly have an incidence of ureteropelvic junction 
obstruction (UPJO) of 15-33%.[2] The increased incidence of UPJO may be related to 
several factors including the high insertion of the ureter into the renal pelvis, the 
anatomic relation of the ureter to the isthmus, and the highly variable blood supply to the 
kidney. The development of urolithiasis, which occurs in 21-60% of patients, as well as 
associated anatomical abnormalities, which occur in up to 30% of these patients, may 
also play a role. [3] 
 The minimally invasive treatment of UPJO in anatomically normal kidneys has 
been well described.  Although endoscopic (retrograde or antegrade) correction of UPJO 
has been associated with lower success rates, it remains the least invasive option.  
Laparoscopic pyeloplasty has proven to be safe and effective when compared to open 
surgery.[4, 5]  For this procedure, however, a steep learning curve exists that requires 
expertise in intracorporeal suturing and tying with laparoscopic instruments.  However, 
the daVinci ® surgical system (Intuitive Surgical, Sunnyvale, CA) has enabled these 
laparoscopic techniques to be performed with greater ease, shorter operative times, and 
equivalent results. [6] 
 The data regarding the outcomes of minimally invasive treatments for UPJO in 
patients with horseshoe kidney anomalies are limited. Our goal was to compare the 
outcomes and discuss the technical challenges unique to horseshoe anomalies among the 
minimally invasive treatment options.    
Patients and Methods 
 After institutional IRB approval, a retrospective chart review of patients treated 
for UPJO was initiated.  The charts of 279 patients who underwent endoscopic or 
laparoscopic correction of UPJO since 1996 to the present were reviewed.  The clinical 
presentation was reviewed for signs and symptoms of UPJO.  Incidental findings were 
recorded as well.  All patients underwent pre- and post-operative diuretic renography to 
establish baseline renal function as well as degree of obstruction.  All patients underwent 
ureteroscopic examination with endoluminal ultrasound.  The presence of crossing 
vessels, high insertion and segment length were recorded.  For laparoscopic and robotic 
cases, endoluminal ultrasound during a diagnostic endoscopic procedure, or CT 
angiography was obtained to delineate the anatomy of the UPJ and surrounding 
structures.  Patients were followed every 3-6 months for the first year with a diuretic 
renogram and annually thereafter.  When we evaluate our patients using t½ criteria 
success is defined with t½ less than 10 minutes (strict success) or 10 to 20 minutes 
(relative success). When the renogram demonstrates delayed drainage (more than 20 
minutes) but shows relative improvement in the t½ compared to preoperative values, as 
long as the patient remains asymptomatic (subjective success) and the split function 
improves or stays stable, then the repair is also considered patent. Alternatively if the t½ 
demonstrates relative success (10 to 20 minutes) and the patient has a relapse of 
symptoms (subjective failure) and a decline in function by diuretic renogram, the repair is 
considered a failure.  
Endopyelotomy was conducted in a retrograde fashion using a flexible 
ureteroscope with a 1.9 Fr electrode or 365 um laser fiber.  The standard laser setting was 
energy of 1.0 J with a rate of 15 Hz.  The UPJ was incised until the presence of fat.  The 
area was then stented with two double pigtail ureteral stents.   
Laparoscopic pyeloplasty was conducted with a standard transperitoneal approach 
utilizing 3 or 4 trocars, and for the robotic pyeloplasty, a 3-arm set-up was utilized with a 
camera port, two 8-mm robotic ports and an additional 12-mm assistant port for suction 
and suture passing.  An Anderson-Hynes dismembered pyeloplasty was performed in all 
cases.  The isthmus of the horseshoe deformity was not divided.   Our technique for this 
procedure has been described elsewhere. [7]  Because of the similarities between 
laparoscopic and robotic pyeloplasty, the combined success of these procedures was 
reported. 
  
Results 
In the endopyelotomy cohort, 4 males and 2 females were treated with a mean age 
of 43.7 years (range 25-72 years).  Obstruction was on the right in 2 patients, and the left 
in 4. All 6 of these patients presented with primary UPJO.  Of these patients, 2 were 
noted to have crossing vessels by endoluminal ultrasound, 4 were noted to have high 
insertion, and 1 had stone disease on the side of obstruction.  The average length of stay 
was one day with no transfusions performed.  Four patients had sufficient follow-up 
(average of 56 months with a range of 10-108).  All four of these patients had diuretic 
renal scans > 6 months after the procedure.  Three patients were successfully treated at 
last follow-up with no symptoms and unobstructed diuretic renograms (one was 
indeterminate with a t½ of 17 minutes).  The one documented failure presented with 
recurrent renal colic and was determined to be obstructed on renogram.  The overall 
success rate was 75%.   
In the laparoscopic/robotic cohort, the average age was 57 years.  Two of the 
three patients presented with secondary UPJO (previous endopyelotomy).  One was noted 
to have a crossing vessel at the transition point of the obstruction. All three patients had 
sufficient follow-up (mean of 21 months).  Two patients were successfully treated with 
resolution of symptoms and obstruction by renal scan.  The one failure alternatively had 
both persistent symptoms and continued obstruction on renal scan.  For the laparoscopic 
procedures, the average length of stay was 2.5 days, blood loss was minimal and mean 
OR time was 390 minutes.  For the robotic pyeloplasty, operative time was 
approximately 210 minutes with minimal blood loss <25 ml and a 2-day length of stay.  
Table 1 is a summary of our results. Our over-all success rate for the combined 
laparoscopic/robotic cohort was 67%. 
 
Discussion 
 Horseshoe kidneys were first described in the early autopsy studies of De Carpi in 
1522, and in a more detailed fashion, the work of Morgagni in 1820. [8] Since then, a 
great deal of data has been made available regarding this congenital anomaly. Although 
most cases are asymptomatic, horseshoe kidneys are associated with a higher incidence 
of UPJO and urolithiasis. [2, 8, 9] 
In 1975, Pitts and associates published their experience with 170 patients with 
horseshoe kidneys over a 40 year period. [8] Of these patients, 15% presented with UPJO. 
This series retrospectively noted an 80% success rate of Foley Y-V open pyeloplasty, 
although no follow-up was mentioned. In 1984, Das et al reported a success rate of open 
pyeloplasties in horseshoe kidneys of 55% (n=5). [10] 
The first minimally invasive option for UPJO was an endoscopic intervention via 
retrograde or antegrade approach.  In 1998, Jabbour et al published their experience with 
antegrade percutaneous endopyelotomy in horseshoe (4) and ectopic (5) kidneys. [2]  Of 
the horseshoe kidneys, 75% were noted to have clear improvement on follow-up IVP 
with reduction of hydronephrosis and rapid emptying of the renal pelvis and early 
visualization of the ureter. These three patients were also noted to be asymptomatic with 
a mean follow-up of 62 months. This success rate, although of a small sample, is identical 
to our endoscopic management of this condition.  
Horseshoe kidneys, however, by definition contain anomalous blood supply and 
are prone to crossing vessels at the UPJ, and the presence of crossing vessels has been 
identified as a major risk in endopyelotomy failures (up to 87%) for both normal and 
malformed kidneys. [11] When we plan an endopyelotomy for a horseshoe kidney, we 
always perform an endoluminal ultrasound in the same setting in order to evaluate the 
UPJ.  If we feel that the patient is a candidate for endopyelotomy, the endoluminal 
ultrasound allows us to plan the incision remote from any anomalous vessels that may be 
in the area.  If, however, crossing vessels appear to be the etiology or the anatomy is 
otherwise unfavorable, we recommend a pyeloplasty.  Two of the patients in our 
endopyelotomy cohort had crossing vessels, but these patients were considered poor 
surgical candidates for pyeloplasty and it was thought that endopyelotomy was their only 
option.  All patients in the endopyelotomy group had not undergone any prior UPJ 
procedures. 
 In 2004, Bove reported on the Johns Hopkins laparoscopic experience with UPJO 
in malformed kidneys. [12] This series involved 5 horseshoe kidneys, 3 pelvic kidneys, a 
pancake kidney, a malrotated kidney and a duplicated collecting system.  In this study, all 
patients showed clinical and/or radiographic success during follow-up of 32.6 and 21.3 
months, respectively. Mean operative time for all anomalies was 195 minutes and mean 
estimated blood loss was 122 cc with no patients needing blood transfusion. Average 
length of stay was 3.2 days. There were no intra-operative complications. Unfortunately 
these variables were not reported individually for horseshoe kidneys.  In contrast, our 
data includes 2 patients with horseshoe kidneys who were treated laparoscopically for 
UPJO.  
 The choice of whether to perform a robotic or laparoscopic pyeloplasty at our 
institution is surgeon dependent.  In 2005, Chammas and associates published a one-year 
follow-up of 3 patients with horseshoe kidneys who underwent robotic pyeloplasty. [13] 
They found that all patients were both asymptomatic at one year and all had good renal 
function with improved drainage shown by IVU at 3 months. One patient had mild 
hydronephrosis, which resolved after one year. Mean operative time for this group of 
patients was 148.3 minutes. Two patients experienced complications in the post-operative 
period: obstructing urolithiasis and pyelonephritis.  
We successfully treated one patient who had undergone a failed laser 
endopyelotomy in a horseshoe kidney with a robotic pyeloplasty.  Operative time was 
210 minutes, estimated blood loss was 25 mL, and length of stay was 2 days.  She 
remains symptom free and unobstructed on diuretic renogram after 2 years.   All patients 
in our laparoscopic/robotic cohort had undergone a prior failed endopyelotomy, with 1 of 
these having been performed at our institution. 
Table 2 documents a comparison of our results with those reported in the 
literature. 
Our final recommendations for treatment of UPJO in a horseshoe kidney include 
careful delineation of the anomaly with either an endoluminal ultrasound or a CT 
angiogram.  If the patient is considered a poor surgical candidate or if the transition point 
of the UPJO is not involving crossing vessels, endopyelotomy can be attempted with a 
reasonable success rate.  In patients who have, however, undergone a failed 
endopyelotomy or if crossing vessels are the etiology of the UPJO, a laparoscopic/robotic 
pyeloplasty should be undertaken.   
There are some shortcomings of the current study.  First, it is retrospective and 
lends itself to the selection biases of such studies.  Additionally, we were not able to 
obtain records in two of our patients who underwent endopyelotomy who had been lost to 
follow-up; this limits the conclusions that we can make for this procedure.   Finally, our 
overall numbers are somewhat small and it is hard to draw definitive conclusions from 
the study, however we do feel that this is more representative of the rarity of this 
condition and our overall numbers represent, to our knowledge, the largest study to date 
that evaluates treatment of UPJO in a horseshoe kidney. 
 
Conclusion 
 Horseshoe kidneys represent a unique challenge to UPJ reconstruction.  In select 
patients, careful retrograde endoscopic endopyelotomy can result in moderate success 
and remains the least invasive option.  Laparoscopic reconstruction with or without 
robotic assistance yields the highest success rate with long-term durability.  Although 
data on the treatment of ureteropelvic junction obstruction via minimally invasive 
techniques in horseshoe kidneys is limited, our data suggests that endopyelotomy and 
laparoscopic/robotic pyeloplasty are all safe and effective options in well selected 
patients.     
 None of the authors contains any financial interest/arrangement that could be 
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